|
Recognize, Assist, Include, Support and Engage (RAISE) Family Caregiving Advisory Council
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIA
|
Federal and non-federal advisory council is charged with providing recommendations to the Secretary of Health and Human Services on effective models of both family caregiving and support to family caregivers, as well as improving coordination across federal government programs, as mandated by the Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act of 2017.
|
|
Reentry Research Network
|
Committee, Work group, Advisory group, or Task Force
|
ACF, SAMHSA
|
NIDA, OD/DPCPSI/OBSSR
|
This is a subgroup that reports to the Federal Interagency Reentry Council. The purpose of this group is to bring together numerous federal agencies to make communities safer, assist those returning from prison and jail to becoming productive, tax-paying citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. The National Institute on Drug Abuse (NIDA) serves on the HHS Re-entry/CJ working group. Staff meets by phone monthly.
|
|
Regenerative Medicine Innovation Project Senior Oversight Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID, NCATS, NEI, NHLBI, NIA, NIAMS, NIDCD, NIDCR, NIDDK, NINDS
|
The Regenerative Medicine Innovation Project was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).
|
|
Regenerative Medicine Project
|
Research Initiative
|
FDA
|
NIA
|
The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).
|
|
Registry-based studies of hematologic malignancy incidence and survivorship
|
Research Initiative
|
FDA
|
NCI
|
NCI and FDA investigators are collaborating to utilize registry-based data to describe incidence trends of hematologic malignancies as well as second cancer risk and mortality patterns among hematologic malignancy survivors.
|
|
Report Out Session of the HIV-related Intersectional Stigma Research Advances and Opportunities Workshop
|
Meeting/ Workshop
|
OASH
|
OD/DPCPSI/OAR, NIMH
|
On September 18, 2020, join the NIH Office of AIDS Research and the NIMH Division of AIDS Research for a discussion about the outcomes of recent meetings of four workgroups focused on HIV-related intersectional stigma research advances and opportunities. The goal of this virtual workshop is to advance HIV prevention and treatment science, inform the Ending the HIV Epidemic (EHE) initiative, and bolster HIV efforts worldwide.
|
|
RePORT South Africa
|
Research Initiative
|
CDC, OS
|
NIAID
|
RePORT South Africa is a jointly funded project between the National Institutes of Health (NIH), the US President's Emergency Plan for AIDS Relief (PEPFAR), and the South African Medical Research Council and Department of Science and Technology to establish a consortium of Tuberculosis (TB) researchers in South Africa.
|
|
Research in Diabetes Mellitus, Its Complications, and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
The objectives are to identify the determinants and understand the progression of type 2 diabetes, obesity, and other chronic diseases in Native American and related populations.
|
|
Review Policy Committee (RPC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC
|
OD/OER, CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, NIDCD, OD
|
The Review Policy Committee (RPC) is the principal forum for the development, implementation, and evaluation of review policies and procedures for all types of research, training, and development awards submitted to the NIH. RPC membership includes one senior extramural review official from each NIH Institute and Center that has extramural review functions. The RPC has designated liaisons from other HHS agencies including Agency for Healthcare Research and Quality (AHRQ) and Centers for Disease Control and Prevention (CDC).
|
|
Revision of Centers for Disease Control and Prevention (CDC) Guidelines on Hepatitis B
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC
|
The collaboration serves to revise guidelines for managing occupational exposures to the human immunodeficiency virus (HIV) and managing healthcare workers infected with hepatitis B.
|